CYPH
CYPH
NASDAQ · Biotechnology

Cypherpunk Technologies Inc

$0.66
-0.03 (-3.91%)
As of Mar 29, 10:51 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +5,797.0% upside
Low Target $25.17
Average Target $38.72
High Target $55.57
Current Price $0.66
Current
$0.66
Target
$38.72
$25.17 $38.72 avg $55.57
Scenario Analysis
Bear Case
$25.17
3,733.4%
Low target
Base Case
$38.72
+5,797.0%
Avg target
Bull Case
$55.57
+8,363.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$3.70
-82.3% from high
52-Week Low
$0.22
+195.4% from low
Target vs 52W High
$38.72
+946.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%